White House pushes COVID antiviral amid funding stalemate with Congress

By: - April 26, 2022 12:53 pm

Paxlovid, an anti-viral approved for emergency use in the treatment of COVID, has been increased by the federal government. (Photo via Wikimedia Commons | CC-BY-SA 4.0)

Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our web site. Please see our republishing guidelines for use of photos and graphics.

Jennifer Shutt
Jennifer Shutt

Jennifer covers the nation’s capital as a senior reporter for States Newsroom. Her coverage areas include congressional policy, politics and legal challenges with a focus on health care, unemployment, housing and aid to families.

MORE FROM AUTHOR